Innovative therapeutics

Investors

J.P. Morgan Spring Series CEO/R&D Conference Call
Thursday, June 13, 2019
10:00am - 11:00am PDT

Jean-Jacques Bienaime, Chairman and CEO/Hank Fuchs, President, Worldwide R&D

213 KB

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information